LIVES
SAHZU-Harvard International Medical Innovation Forum
-
SAHZU-Harvard International Medical Innovation Forum
19:30–22:05 -
19:30–22:05
Moderators
Albert HofmanChair,DepartmentofEpidemiology,HarvardT.H.ChanSchoolofPublicHealth
-
19:30–19:35
Opening Remarks
Wang Jian'anTheSecondAffiliatedHospitalZhejiangUniversitySchoolofMedicine Chairman
-
19:35–20:00
Randomized Trials of Inflammation Inhibition for Atherosclerotic Disease: Moving From Theory to Practice
Paul M RidkerDirector,CenterforCardiovascularDiseasePrevention,BrighamandWomen’sHospital
-
20:00–20:25
Experience on International Multi-center Clinical Trials
HU XinyangVicePresident,SAHZU,China
-
20:25–20:50
High-quality Clinical Research Fuels Research Hospital
XU RuihuaPresidentandProfessor,SunYat-senUniversityCancerCenter,China
-
20:50–21:15
Target Trial Emulation: a framework to find what works when no randomized trials are available
Miguel HernánDirector,CAUSALab,DepartmentofEpidemiology,HarvardT.H.ChanSchoolofPublicHealth
KolokotronesProfessorofBiostatisticsandEpidemiology,HarvardT.H.ChanSchoolofPublicHealth
-
21:15–21:40
Innovation for Value-Based Care
XIONG LizePresident,ShanghaiFourthPeople’sHospitalAffiliatedtoTongjiUniversity,China
-
21:40–22:05
Platform Clinical Trials, the What, Why and How: Example from ALS
Lori ChibnikDepartmentofEpidemiology,HarvardTHChanSchoolofPublicHealth Associate Professor
DepartmentofNeurology,HarvardMedicalSchool Associate Professor